UTI Prophylaxis Raises Resistance Risk
Study finds more resistance on culture, no significant rise in severe infections
By
Jess Allerton
March 30, 2026
Clinical Scorecard: UTI Prophylaxis Raises Resistance Risk
At a Glance
Category Detail
Condition Recurrent Urinary Tract Infections (UTIs) Key Mechanisms Prophylactic antibiotics increase detection of antibiotic-resistant bacteria in urine cultures. Target Population Women aged 18 years or older with recurrent UTIs. Care Setting Outpatient settings, with data sourced from the Secure Anonymised Information Linkage (SAIL) Databank.
Key Highlights
Prophylactic antibiotics linked to increased antimicrobial resistance on urine culture. No statistically significant increase in hospital admissions for antibiotic-resistant infections. 31% of prophylaxis group showed resistance to at least one antibiotic compared to 24% in non-prophylaxis group. 22% of prophylaxis group had resistance to two or more antibiotics versus 14% in non-prophylaxis group. Escherichia coli was the most common uropathogen identified. Guideline-Based Recommendations
Diagnosis
Consider urine culture to assess for antibiotic resistance in patients with recurrent UTIs. Management
Weigh the benefits of prophylactic antibiotics against the risk of developing antibiotic resistance. Monitoring & Follow-up
Monitor for signs of antibiotic resistance in patients receiving prophylactic antibiotics. Risks
Increased risk of detecting antibiotic-resistant bacteria in urine cultures. Patient & Prescribing Data
Women aged 18 years or older with recurrent UTIs.
Prophylactic antibiotics (nitrofurantoin, trimethoprim, cefalexin) may reduce recurrence but increase resistance.
Clinical Best Practices
Engage in shared decision-making regarding the use of prophylactic antibiotics. Consider individual patient history and potential for antibiotic resistance. References
